Beta-glucan and arabinogalactan-based xerogels for abuse-deterrent opioid formulations. [electronic resource]
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Mar 2019
- 132-139 p. digital